Dextrose 5% in water bilateral injection — Competitive Intelligence Brief

Dextrose 5% in water bilateral injection (Dextrose 5% in water bilateral injection) competitive landscape: 2 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Intravenous fluid / Carbohydrate solution. Area: Supportive Care / Fluid & Electrolyte Management.

marketed Intravenous fluid / Carbohydrate solution Supportive Care / Fluid & Electrolyte Management Small molecule

Target snapshot

Dextrose 5% in water bilateral injection (Dextrose 5% in water bilateral injection) — Dr. Dean Reeves Clinic. Dextrose 5% in water provides intravenous hydration and a source of glucose for systemic energy metabolism.

Comparator set (2 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Dextrose 5% in water bilateral injection TARGET	Dextrose 5% in water bilateral injection	Dr. Dean Reeves Clinic	marketed	Intravenous fluid / Carbohydrate solution
Dextrose Water	Dextrose Water	University of Michigan	marketed	Intravenous fluid / Carbohydrate solution
Dextrose 5% (D5W)	Dextrose 5% (D5W)	Universidad Abierta Interamericana	marketed	Intravenous fluid / Carbohydrate solution

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Intravenous fluid / Carbohydrate solution class)

1. Dr. Dean Reeves Clinic · 1 drug in this class
2. Universidad Abierta Interamericana · 1 drug in this class
3. University of Michigan · 1 drug in this class